Advisor Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-45,514
Closed -$4.52M 5667
2019
Q3
$4.52M Sell
45,514
-6,621
-13% -$629K 0.03% 446
2019
Q2
$4.82M Buy
52,135
+3,705
+8% +$352K 0.04% 395
2019
Q1
$4.57M Sell
48,430
-36,711
-43% -$3.21M 0.04% 399
2018
Q4
$5.46M Buy
85,141
+9,958
+13% +$735K 0.05% 297
2018
Q3
$6.73M Buy
75,183
+16,239
+28% +$1.44M 0.07% 239
2018
Q2
$4.68M Sell
58,944
-7,859
-12% -$653K 0.06% 260
2018
Q1
$5.96M Buy
66,803
+3,650
+6% +$350K 0.08% 217
2017
Q4
$6.59M Sell
63,153
-5,329
-8% -$601K 0.09% 204
2017
Q3
$9.99M Buy
68,482
+7,506
+12% +$1.02M 0.16% 132
2017
Q2
$7.92M Buy
60,976
+2,561
+4% +$314K 0.14% 149
2017
Q1
$7.27M Buy
58,415
+3,694
+7% +$442K 0.15% 150
2016
Q4
$6.33M Buy
54,721
+1,750
+3% +$195K 0.14% 156
2016
Q3
$5.54M Buy
52,971
+2,192
+4% +$237K 0.13% 171
2016
Q2
$5.01M Buy
+50,779
New +$5.25M 0.13% 178

Other funds holding CELG

Advisor Group's CELG Position: Q4 2019 in Review

Advisor Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 45,514 shares — an estimated $4.52M sold.

Advisor Group first reported a position in CELG in Q2 2016 and held it in 14 quarters. The position peaked at $9.99M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Advisor Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Advisor Group sold 45,514 Celgene Corp shares in Q4 2019, an estimated $4.52M.
  • Advisor Group first reported a position in Celgene Corp in Q2 2016 and held it in 14 quarters.
  • Advisor Group's Celgene Corp position peaked at $9.99M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.